首页> 美国卫生研究院文献>World Journal of Gastrointestinal Oncology >Clinical significance of lymphadenectomy in patients with gastric cancer
【2h】

Clinical significance of lymphadenectomy in patients with gastric cancer

机译:胃癌患者淋巴结清扫术的临床意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Approximately thirty percent of patients with gastric cancer undergo an avoidable lymph node dissection with a higher rate of postoperative complication. Comparing the D1 and D2 dissections, it was found that there is a significant difference in morbidity, favoured D1 dissection without any difference in overall survival. Subgroup analysis of patients with T3 tumor shows a survival difference favoring D2 lymphadenectomy, and there is a better gastric cancer-related death and non-statistically significant improvement of survival for node-positive disease in patients with D2 dissection. However, the extended lymphadenectomy could improve stage-specific survival owing to the stage migration phenomenon. The deployment of centralization and application of national guidelines could improve the surgical outcomes. The Japanese and European guidelines enclose the D2 lymphadenectomy as the gold standard in R0 resection. In the individualized, stage-adapted gastric cancer surgery the Maruyama computer program (MCP) can estimate lymph node involvement preoperatively with high accuracy and in addition the Maruyama Index less than 5 has a better impact on survival, than D-level guided surgery. For these reasons, the preoperative application of MCP is recommended routinely, with an aim to perform “low Maruyama Index surgery”. The sentinel lymph node biopsy (SNB) may decrease the number of redundant lymphadenectomy intraoperatively with a high detection rate (93.7%) and an accuracy of 92%. More accurate stage-adapted surgery could be performed using the MCP and SNB in parallel fashion in gastric cancer.
机译:大约30%的胃癌患者接受可避免的淋巴结清扫术,术后并发症发生率更高。比较D1和D2夹层,发现发病率有显着差异,有利于D1夹层,但总生存率没有任何差异。对T3肿瘤患者进行亚组分析显示,生存差异有利于D2淋巴结清扫术,D2淋巴结清扫术患者的淋巴结阳性疾病具有更好的胃癌相关死亡和无统计学显着的生存改善。然而,由于阶段迁移现象,扩大的淋巴结清扫术可以改善特定阶段的生存。集中部署和应用国家指南可以改善手术效果。日本和欧洲指南将D2淋巴结清扫术作为R0切除术的金标准。在个性化,分阶段适应的胃癌手术中,丸山计算机程序(MCP)可以准确地估计术前淋巴结受累,此外,丸山指数小于5对生存率的影响比D级引导性手术更好。由于这些原因,常规建议在术前应用MCP,以进行“低丸山指数手术”。前哨淋巴结活检(SNB)可减少术中重复的淋巴结清扫术的次数,检出率高(93.7%),准确度达92%。在胃癌中,可以并行使用MCP和SNB进行更准确的分期手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号